Report Content
Chapter 1 Methodology
1.1 Methodology
1.2 Market definitions
1.3 Forecast parameters
1.4 Data sources
1.4.1 Secondary
1.4.1.1 Paid sources
1.4.1.2 Unpaid sources
1.4.2 Primary
Chapter 2 Executive Summary
2.1 Biodefense industry 360° synopsis, 2017 - 2028
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Regional trends
Chapter 3 Biodefense Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2028
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Technological advancements in biotechnology sector in North America and Europe
3.3.1.2 Favorable government initiatives in Asia Pacific and Latin America
3.3.1.3 Growing investments by government in R&D in North America & Europe
3.3.2 Industry pitfalls & challenges
3.3.2.1 Low R&D funding by government in underdeveloped regions
3.4 Growth potential analysis
3.4.1 By product
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 Competitive landscape, 2021
3.7.1 Company matrix analysis, 2021
3.8 PESTEL analysis
Chapter 4 Biodefense Market, By Product
4.1 Key segment trends
4.2 Vaccines
4.2.1 Market size, by region, 2017 - 2028 (USD Million)
4.2.2 Anthrax
4.2.2.1 Market size, by region, 2017 - 2028 (USD Million)
4.2.3 Smallpox
4.2.3.1 Market size, by region, 2017 - 2028 (USD Million)
4.2.4 Botulism
4.2.4.1 Market size, by region, 2017 - 2028 (USD Million)
4.2.5 Others
4.2.5.1 Market size, by region, 2017 - 2028 (USD Million)
4.3 Biothreat detection devices
4.3.1 Market size, by region, 2017 - 2028 (USD Million)
4.3.2 Samplers
4.3.2.1 Market size, by region, 2017 - 2028 (USD Million)
4.3.3 Detectors/triggering devices
4.3.3.1 Market size, by region, 2017 - 2028 (USD Million)
4.3.4 Identifiers
4.3.4.1 Market size, by region, 2017 - 2028 (USD Million)
4.3.5 Assays and reagents
4.3.5.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 5 Biodefense Market, By Region
5.1 Key regional trends
5.2 North America
5.2.1 Market size, by country, 2017 - 2028 (USD Million)
5.2.2 Market size, by product, 2017 - 2028 (USD Million)
5.2.2.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.2.2.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.2.3 U.S.
5.2.3.1 Market size, by product, 2017 - 2028 (USD Million)
5.2.3.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.2.3.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.2.4 Canada
5.2.4.1 Market size, by product, 2017 - 2028 (USD Million)
5.2.4.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.2.4.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.3 Europe
5.3.1 Market size, by country, 2017 - 2028 (USD Million)
5.3.2 Market size, by Product, 2017 - 2028 (USD Million)
5.3.2.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.3.2.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.3.3 Germany
5.3.3.1 Market size, by product, 2017 - 2028 (USD Million)
5.3.3.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.3.3.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.3.4 UK
5.3.4.1 Market size, by product, 2017 - 2028 (USD Million)
5.3.4.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.3.4.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.3.5 France
5.3.5.1 Market size, by product, 2017 - 2028 (USD Million)
5.3.5.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.3.5.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.3.6 Spain
5.3.6.1 Market size, by product, 2017 - 2028 (USD Million)
5.3.6.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.3.6.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.4 Asia Pacific
5.4.1 Market size, by country, 2017 - 2028 (USD Million)
5.4.2 Market size, by product, 2017 - 2028 (USD Million)
5.4.2.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.4.2.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.4.3 Japan
5.4.3.1 Market size, by product, 2017 - 2028 (USD Million)
5.4.3.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.4.3.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.4.4 China
5.4.4.1 Market size, by product, 2017 - 2028 (USD Million)
5.4.4.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.4.4.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.4.5 India
5.4.5.1 Market size, by product, 2017 - 2028 (USD Million)
5.4.5.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.4.5.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.5 Latin America
5.5.1 Market size, by country, 2017 - 2028 (USD Million)
5.5.2 Market size, by product, 2017 - 2028 (USD Million)
5.5.2.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.5.2.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.5.3 Brazil
5.5.3.1 Market size, by product, 2017 - 2028 (USD Million)
5.5.3.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.5.3.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.5.4 Mexico
5.5.4.1 Market size, by product, 2017 - 2028 (USD Million)
5.5.4.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.5.4.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.5.5 Argentina
5.5.5.1 Market size, by product, 2017 - 2028 (USD Million)
5.5.5.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.5.5.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.6 MEA
5.6.1 Market size, by country, 2017 - 2028 (USD Million)
5.6.2 Market size, by product, 2017 - 2028 (USD Million)
5.6.2.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.6.2.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.6.3 South Africa
5.6.3.1 Market size, by product, 2017 - 2028 (USD Million)
5.6.3.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.6.3.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.6.4 Saudi Arabia
5.6.4.1 Market size, by product, 2017 - 2028 (USD Million)
5.6.4.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.6.4.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
5.6.5 UAE
5.6.5.1 Market size, by product, 2017 - 2028 (USD Million)
5.6.5.1.1 Market size, by vaccines, 2017 - 2028 (USD Million)
5.6.5.1.2 Market size, by biothreat detection devices, 2017 - 2028 (USD Million)
Chapter 6 Company Profiles
6.1 Strategy dashboard, 2021
6.2 Alexeter Technologies, LLC
6.2.1 Business overview
6.2.2 Financial data
6.2.3 Product landscape
6.2.4 Strategic outlook
6.2.5 SWOT analysis
6.3 Altimmune
6.3.1 Business overview
6.3.2 Financial data
6.3.3 Product landscape
6.3.4 Strategic outlook
6.3.5 SWOT analysis
6.4 ANP Technologies
6.4.1 Business overview
6.4.2 Financial data
6.4.3 Product landscape
6.4.4 Strategic outlook
6.4.5 SWOT analysis
6.5 Bavarian Nordic
6.5.1 Business overview
6.5.2 Financial data
6.5.3 Product landscape
6.5.4 Strategic outlook
6.5.5 SWOT analysis
6.6 BioFire Defense (bioMérieux SA)
6.6.1 Business overview
6.6.2 Financial data
6.6.3 Product landscape
6.6.4 Strategic outlook
6.6.5 SWOT analysis
6.7 Biosearch Technologies
6.7.1 Business overview
6.7.2 Financial data
6.7.3 Product landscape
6.7.4 Strategic outlook
6.7.5 SWOT analysis
6.8 Bruker Detection
6.8.1 Business overview
6.8.2 Financial data
6.8.3 Product landscape
6.8.4 Strategic outlook
6.8.5 SWOT analysis
6.9 Electronic Sensor Technology Inc.
6.9.1 Business overview
6.9.2 Financial data
6.9.3 Product landscape
6.9.4 Strategic outlook
6.9.5 SWOT analysis
6.10 Elusys Therapeutics
6.10.1 Business overview
6.10.2 Financial data
6.10.3 Product landscape
6.10.4 Strategic outlook
6.10.5 SWOT analysis
6.11 Emergent BioSolutions
6.11.1 Business overview
6.11.2 Financial data
6.11.3 Product landscape
6.11.4 Strategic outlook
6.11.5 SWOT analysis
6.12 Ichor Medical Systems, Inc.
6.12.1 Business overview
6.12.2 Financial data
6.12.3 Product landscape
6.12.4 Strategic outlook
6.12.5 SWOT analysis
6.13 Nanologix
6.13.1 Business overview
6.13.2 Financial data
6.13.3 Product landscape
6.13.4 Strategic outlook
6.13.5 SWOT analysis
6.14 New Horizon Diagnostic Corp.
6.14.1 Business overview
6.14.2 Financial data
6.14.3 Product landscape
6.14.4 Strategic outlook
6.14.5 SWOT analysis
6.15 PositiveID Corporation
6.15.1 Business overview
6.15.2 Financial data
6.15.3 Product landscape
6.15.4 Strategic outlook
6.15.5 SWOT analysis
6.16 SIGA Technologies
6.16.1 Business overview
6.16.2 Financial data
6.16.3 Product landscape
6.16.4 Strategic outlook
6.16.5 SWOT analysis
6.17 Smiths Detection Group Ltd.
6.17.1 Business overview
6.17.2 Financial data
6.17.3 Product landscape
6.17.4 Strategic outlook
6.17.5 SWOT analysis
6.18 Synexis Systems
6.18.1 Business overview
6.18.2 Financial data
6.18.3 Product landscape
6.18.4 Strategic outlook
6.18.5 SWOT analysis
